{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:10:53Z","timestamp":1774260653249,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10157-026-02823-y","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:33:24Z","timestamp":1770032004000},"page":"615-621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary thrombin as a non-invasive biomarker in renal diseases: a possible role in the detection of segmental sclerosis lesions in IgA nephropathy"],"prefix":"10.1007","volume":"30","author":[{"given":"Yoshikazu","family":"Miyasato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terumasa","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kakizoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Nagayoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Nishiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Mukoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Kitamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5139-2532","authenticated-orcid":false,"given":"Masataka","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2823_CR1","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","volume":"64","author":"TK Vu","year":"1991","unstructured":"Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057\u201368.","journal-title":"Cell"},{"key":"2823_CR2","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/oxfordjournals.bmb.a072935","volume":"50","author":"MJ Rabiet","year":"1994","unstructured":"Rabiet MJ, Plantier JL, Dejana E. Thrombin-induced endothelial cell dysfunction. Br Med Bull. 1994;50:936\u201345.","journal-title":"Br Med Bull"},{"key":"2823_CR3","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/cells12091222","volume":"12","author":"J Iannucci","year":"2023","unstructured":"Iannucci J, Grammas P. Thrombin, a key driver of pathological inflammation in the brain. Cells. 2023;12:1222.","journal-title":"Cells"},{"key":"2823_CR4","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/jth.15663","volume":"20","author":"S Peraramelli","year":"2022","unstructured":"Peraramelli S, Zhou Q, Zhou Q, et al. Thrombin cleavage of osteopontin initiates osteopontin\u2019s tumor\u2010promoting activity. J Thromb Haemost. 2022;20:1256\u201370.","journal-title":"J Thromb Haemost"},{"key":"2823_CR5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0272-6386(00)70022-9","volume":"35","author":"G Grandaliano","year":"2000","unstructured":"Grandaliano G, Gesualdo L, Ranieri E, Monno R, Schena FP. Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis. Am J Kidney Dis. 2000;35:726\u201338.","journal-title":"Am J Kidney Dis"},{"key":"2823_CR6","doi-asserted-by":"publisher","first-page":"F1140","DOI":"10.1152\/ajprenal.00460.2016","volume":"311","author":"O Palygin","year":"2016","unstructured":"Palygin O, Ilatovskaya DV, Staruschenko A. Protease-activated receptors in kidney disease progression. Am J Physiol Renal Physiol. 2016;311:F1140\u20134.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2823_CR7","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1681\/ASN.2016070789","volume":"28","author":"R Sharma","year":"2017","unstructured":"Sharma R, Waller AP, Agrawal S, et al. Thrombin-induced podocyte injury is protease-activated receptor dependent. J Am Soc Nephrol. 2017;28:2618\u201330.","journal-title":"J Am Soc Nephrol"},{"key":"2823_CR8","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2337\/db23-0032","volume":"72","author":"R Bohovyk","year":"2023","unstructured":"Bohovyk R, Khedr S, Levchenko V, et al. Protease-activated receptor 1\u2013mediated damage of podocytes in diabetic nephropathy. Diabetes. 2023;72:1795\u2013808.","journal-title":"Diabetes"},{"key":"2823_CR9","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1046\/j.1523-1755.1998.00169.x","volume":"54","author":"Y Kitamoto","year":"1998","unstructured":"Kitamoto Y, Imamura T, Fukui H, Tomita K. Role of thrombin in mesangial proliferative glomerulonephritis. Kidney Int. 1998;54:1767\u20138.","journal-title":"Kidney Int"},{"key":"2823_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1258\/000456304322880023","volume":"41","author":"Y Kitamoto","year":"2004","unstructured":"Kitamoto Y, Tomita K, Imamura T. Assessment of thrombin in the urine of glomerulonephritic patients by enzyme-linked immunosorbent assay. Ann Clin Biochem. 2004;41:133\u20137.","journal-title":"Ann Clin Biochem"},{"key":"2823_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118704","volume":"10","author":"Y Kitamoto","year":"2015","unstructured":"Kitamoto Y, Arizono K, Fukui H, et al. Urinary thrombin: a novel marker of glomerular inflammation for the diagnosis of crescentic glomerulonephritis (prospective observational study). PLoS ONE. 2015;10:e0118704.","journal-title":"PLoS ONE"},{"key":"2823_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1620\/tjem.253.41","volume":"253","author":"Y Kitamoto","year":"2021","unstructured":"Kitamoto Y, Imamura T, Taguma Y, Iwaoka T, Yorinaka H, Arizono K. Urinary thrombin as a marker of glomerular inflammation associated with renal injury in type 2 diabetes. Tohoku J Exp Med. 2021;253:41\u20139.","journal-title":"Tohoku J Exp Med"},{"key":"2823_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/sj.ki.5002655","volume":"73","author":"VD D\u2019Agati","year":"2008","unstructured":"D\u2019Agati VD. Podocyte injury in focal segmental glomerulosclerosis: lessons from animal models (a play in five acts). Kidney Int. 2008;73:399\u2013406.","journal-title":"Kidney Int"},{"key":"2823_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0272-6386(04)01081-9","volume":"44","author":"C Kitiyakara","year":"2004","unstructured":"Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis. 2004;44:815\u201325.","journal-title":"Am J Kidney Dis"},{"key":"2823_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15020120","volume":"15","author":"G Figueiredo","year":"2025","unstructured":"Figueiredo G, Yu L, Jorge LB, Woronik V, Dias CB. Nephrotic and non-nephrotic focal segmental glomerulosclerosis: clinical characteristics, etiology, and Columbia classification. Diagnostics (Basel). 2025;15:120.","journal-title":"Diagnostics (Basel)"},{"key":"2823_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00476-9","volume":"9","author":"E Stamellou","year":"2023","unstructured":"Stamellou E, Seikrit C, Tang SCW, et al. IgA nephropathy. Nat Rev Dis Primers. 2023;9:67.","journal-title":"Nat Rev Dis Primers"},{"key":"2823_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/ki.2010.460","volume":"79","author":"K El Karoui","year":"2011","unstructured":"El Karoui K, Hill GS, Karras A, et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int. 2011;79:643\u201354.","journal-title":"Kidney Int"},{"key":"2823_CR18","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91:1014\u201321.","journal-title":"Kidney Int"},{"key":"2823_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/1536867X0200200307","volume":"2","author":"MA Cleves","year":"2002","unstructured":"Cleves MA. From the help desk: comparing areas under receiver operating characteristic curves from two or more probit or logit models. Stata J Promot Commun Stat Stata. 2002;2:301\u201313.","journal-title":"Stata J Promot Commun Stat Stata"},{"key":"2823_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","volume":"361","author":"A Rajasekaran","year":"2021","unstructured":"Rajasekaran A, Julian BA, Rizk DV. IgA nephropathy: an interesting autoimmune kidney disease. Am J Med Sci. 2021;361:176\u201394.","journal-title":"Am J Med Sci"},{"key":"2823_CR21","unstructured":"Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009; 76:534\u201345."},{"key":"2823_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239064","volume":"21","author":"D Maixnerova","year":"2020","unstructured":"Maixnerova D, Tesar V. Emerging modes of treatment of IgA nephropathy. Int J Mol Sci. 2020;21:9064.","journal-title":"Int J Mol Sci"},{"key":"2823_CR23","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(23)02302-4","volume":"402","author":"BH Rovin","year":"2023","unstructured":"Rovin BH, Barratt J, Heerspink HJL, et al. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial. Lancet. 2023;402:2077\u201390.","journal-title":"Lancet"},{"key":"2823_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1155\/2013\/623196","volume":"34","author":"A Korzeniecka-Kozerska","year":"2013","unstructured":"Korzeniecka-Kozerska A, Wasilewska A, Tenderenda E, Sulik A, Cybulski K. Urinary MMP-9\/NGAL ratio as a potential marker of FSGS in nephrotic children. Dis Markers. 2013;34:357\u201362.","journal-title":"Dis Markers"},{"key":"2823_CR25","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.ekir.2023.06.016","volume":"8","author":"DJ Caster","year":"2023","unstructured":"Caster DJ, Abner CW, Walker PD, et al. Clinicopathological characteristics of adult IgA nephropathy in the United States. Kidney Int Rep. 2023;8:1792\u2013800.","journal-title":"Kidney Int Rep"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02823-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02823-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02823-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T09:28:23Z","timestamp":1774258103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02823-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2823"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02823-y","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared no conflict of interest regarding this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Kumamoto University Hospital (No. 1208).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}